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SUMMARY
The Schistosoma mansoni cercarial elastase (SmCE) has previously been shown to be poorly immunogenic in mice.
However, a minority of mice were able to produce antibodies against SmCE after multiple immunizations with crude pre-
parations containing the enzyme. These mice were partially protected against challenge infections of S. mansoni. In the
present study, we show that in contrast to the poor immunogenicity of the enzymatically active native form of SmCE
derived from a crude preparation (cercarial transformation ﬂuid), immunization of CBA/Ca mice with two enzymatically
inactive forms, namely puriﬁed native SmCE or a recombinant SmCE fused to recombinant Schistosoma japonicum gluta-
thione S-transferase (rSmCE-SjGST), after adsorption onto aluminum hydroxide adjuvant, induced speciﬁc anti-SmCE
immunoglobulin G (IgG) in all mice within 2 weeks of the second immunization. The IgG antibody response to rSmCE-
SjGST was mainly of the IgG1 subclass. These results suggest that inactive forms of the antigen could be used to obtain
the optimum immunogenic eﬀects as a vaccine candidate against schistosomiasis. Mice immunized with the rSmCE-
SjGST on alum had smaller mean worm burdens and lower tissue egg counts when compared with adjuvant alone-
and recombinant SjGST-injected controls. The native SmCE was antigenically cross-reactive with homologous
enzymes of Schistosoma haematobium and Schistosoma margrebowiei.
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INTRODUCTION
With only a single drug and no vaccine, the global
elimination of schistosomiasis is a real challenge
(Hotez et al. 2014). Only a few schistosome antigens
have induced signiﬁcant protection in experimental
animals, and results of early experiments were often
not reproducible (Bergquist and Colley, 1998).
Many of these antigens were selected because they
were capable of inducing strong antibody responses
in infected hosts. In the 1970s, ByronWaksman pro-
posed that such antigens may be inappropriate for
vaccine development as the parasite appears to be
able to survive despite the presence of high levels
of antibodies against the antigens in question.
Waksman’s postulate was publicized by Sher
(1988) and it predicates that it would be more expe-
dient to investigate the vaccine potential of mole-
cules that are likely to be important for parasite
survival, but not so well recognized by the host’s
immune response (Sher, 1988; Doenhoﬀ, 1998).
One such example is the Schistosoma mansoni
cercarial elastase (SmCE), the major proteolytic
activity responsible for degradation of the diverse
set of macromolecular barriers that cercariae must
breach during penetration of host skin (Salter et al.
2002). Immune responses, which can neutralize the
activity of SmCE, may thus protect the host by pre-
venting or delaying penetration of cercariae and
migration of schistosomula through the skin
(Cohen et al. 1991). Previous reports of the likeli-
hood that SmCE is also expressed on the surface of
older skin and lung schistosomula (Marikovsky
et al. 1990a,b; Ghendler et al. 1996; Fitzpatrick
et al. 2009) may mean that the enzyme can also
potentiate parasite survival during later stages of
infection.
SmCE was not recognized as an antigen by anti-
bodies in sera from schistosome-infected patients
or animals (Bahgat et al. 2001) and its native form
was found to be poorly immunogenic when injected
into mice (Darani et al. 1997). In the latter study, a
few mice repeatedly immunized with the native elas-
tase did, however, produce anti-elastase antibodies
and were found to be signiﬁcantly protected
against a challenge of S. mansoni cercariae. In this
study, we present data on the immunogenicity in
mice of an enzymatically inactive SmCE puriﬁed
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from cercarial transformation ﬂuid (CTF) and a
recombinant full-length, inactive SmCE fused to
the Schistosoma japonicum glutathione S-transferase
(SjGST) protein (rSmCE-SjGST) compared with
the native, active SmCE present in a crude prepar-
ation [S. mansoni CTF (SmCTF)].
MATERIALS AND METHODS
Parasites and animals
A Puerto Rican strain of S. mansoni was maintained
by passage through CBA/Ca inbred mice (supplied
by Charles River, UK) and Biomphalaria glabrata
snails using previously described methods (Smithers
and Terry, 1965; Doenhoﬀ et al. 1978a). Life cycles
of Schistosoma haematobium and Schistosoma margre-
bowiei were maintained in Syrian golden hamsters
and Bulinus globosus snails. All work with laboratory
animals was conducted according to the UK Animal
(Scientiﬁc Procedures) Act 1986 with personal
Q2 and project licence authorities held by MJD
(numbers PIL70/3255 and PPL40/3024, respect-
ively). Animals were killed by administration of a
lethal dose of pentobarbitone anaesthetic. Mice
were perfused 42 days after cercarial challenge
using previously described methods for enumeration
of worms followed by tissue digestion for estimation
of tissue egg loads (Doenhoﬀ et al. 1978a,b).
SmCTF and S. haematobium CTF (ShCTF) and
cercarial homogenates from S. mansoni (SmCH),
S. haematobium (ShCH) and S. margrebowiei
(SmrgCH) were derived from their respective mech-
anically transformed cercariae as described else-
where (Colley and Wikel, 1974; Smith et al. 2012),
kept frozen at −80 °C until required for use.
Rabbit antisera reactive with SmCE, S. haematobium
cercarial elastase (ShCE) or SjGST
SmCTF or ShCTF were run in sodium dodecyl sul-
phate–polyacrylamide gel electrophoresis (SDS–
PAGE) gels and transferred onto nitrocellulose
papers (NCPs) as previously described (Laemmli,
1970; Towbin et al. 1979). The respective ∼27 kDa
cercarial elastase bands were excised and the NCP
strip was dissolved in the minimum amount of
dimethyl formamide, diluted in an equal volume of
isotonic saline and emulsiﬁed with Freund’s adju-
vants (Difco Laboratories, USAQ3 ), Freund’s com-
plete adjuvant being used for the ﬁrst injection and
Freund’s incomplete adjuvant for the boosting
injections. New Zealand white rabbits (B&K
Universal, UK) were subcutaneously immunized
with 0·5 mL of the material every 2 weeks until the
sera were shown by an appropriate immunoassay
(immunoprecipitation or immunoblotting) to have
antibody reactivity. The rabbits were then exsangui-
nated and their sera were collected and stored at
−20 °C until required. Sera from rabbits injected
with Freund’s adjuvant alone were used as controls
for the cross-reactivity experiment. The anti-
SjGST rabbit antiserum was produced by injecting
rabbits with SjGST (5 mg protein/injection) that
had been puriﬁed from the S. japonicum worm hom-
ogenate by glutathione S-transferase (GST) aﬃnity
chromatography as previously described (Simons
and Vander Jagt, 1981), emulsiﬁed with Freund’s
adjuvants as described above.
Plasmids and chemicals
All chemicals, antibiotics and components of
bacterial growth media were purchased from
Sigma (Poole, UK), unless otherwise indicated. A
plasmid expressing the SmCE-GST fusion protein
(pGEXCEL) was constructed from a full-length
SmCE-1a cDNA clone based on the S. mansoni elas-
tase HP1 gene (gi 1240057) in pBluescript II SK
(designated pCEL, supplied by Jamile Khalife,
Institute Pasteur, Lille, France) and the pGEXON1
vector expressing exon 1 of SmCE-1a as a SjGST
fusion (Price et al. 1997). The plasmid pGEXON1
encodes amino-acid residues 27–78 of the SmCE-
1a protein (accession number CAA94312, encoded
by Genbank Z70296) cloned in-frame with the
pGEX-KG GST fusion gene. Brieﬂy, the pCEL
was digested with EcoRI and SmaI to excise the
SmCE cDNA fragment, minus 36 nucleotides at
the 5′ end of the mature protein-coding sequence.
The resulting EcoRI-SmaI excised fragment encod-
ing residues 37–264 of mature SmCE-1a was then
ligated into pGEXON1 that had been digested
with HindIII, blunt ended, puriﬁed and digested
with EcoRI (to remove the ﬁrst exon insert except
for 36 nucleotides at the insert 5′ end that were left
in the correct reading frame downstream to the
SjGST cDNA in the vector) using standard molecu-
lar biology methods (Sambrook et al. 1989). Thus,
the ﬁnal construct, pGEXCEL, encodes the
SjGST gene fused in-frame with residues 27–264
of SmCE-1a (mature SmCE-1a).
Cloning and expression of rSmCE-SjGST and
recombinant SjGST (rSjGST)
pGEXCEL vector DNA was transformed sequen-
tially into competent JM109 Escherichia coli cells
using standard procedures (Sambrook et al. 1989)
in order to express the rSmCE-SjGST fusion
protein (Guan and Dixon, 1991). The pGEX-KG
vector was used to transform the same cells to
express the rSjGST protein. General procedures
for cloning, DNA manipulations and protein
expression were performed as described elsewhere
(Simons and Vander Jagt, 1981; Sambrook et al.
1989). The cells were harvested by centrifuging the
culture mix at 5000 × g for 10 min (min) at 4 °C.




























































The resulting cell pellet (5 g) was used to extract the
recombinant protein by resuspension in 50 mL of
50 mM Tris–HCl, pH 8·0, 1 mM EDTA), 200 mM
NaCl and 5% glycerol (v/v). Freshly prepared phe-
nylmethanesulphonyl ﬂuoride and lysozyme were
added to ﬁnal concentrations of 23 µg mL−1 and
10 mg mL−1, respectively, and the suspension was
stirred for 20 min at room temperature (RT) until
it became viscous. Sodium deoxycholate solution
(50 mg in 1 mL) was added and the mixture was
stirred vigorously for a further 20 min at RT and
sonicated (4 × 10 s bursts, 25% amplitude, separated
by 10 s incubations on ice). The suspension was
clariﬁed by centrifugation at 42 000 × g for 30 min
at 4 °C. To prepare puriﬁed soluble rSjGST, the
supernatants from this step using extracts from
cells carrying the unmodiﬁed vector pGEX-KG
were applied to HiTrap GST columns (GE Health-
care). The pellet containing the insoluble rSmCE-
SjGST protein was solubilized by re-suspending
in phosphate-buﬀered saline (PBS), pH 7·2, con-
taining 8 M urea at RT with shaking for 30 min, cen-
trifuged as above, and the supernatants containing
solubilized proteins were retained for puriﬁcation
of rSmCE-SjGST.
Antigen puriﬁcation and immunization of mice
Native SmCE (giving a doublet of protein bands at
∼27/28 kDa in SDS–PAGE) was puriﬁed from
SmCTF by continuous-elution gel electrophoresis
using the BIORAD Electro-Eluter model 422 (Bio-
RAD), according to the manufacturer’s instructions.
An electroblot of the fraction containing the puriﬁed
SmCE was stained with Protogold® (a colloidal gold
solution; BioCell Research Labs, UK) according to
the manufacturer’s instructions. Suspensions
containing rSmCE-SjGST solubilized in 8 M urea
were loaded onto 10% SDS–PAGE gels, and the
protein was puriﬁed by continuous-elution gel elec-
trophoresis using the BIORAD Prep Cell model
491 (Bio-RAD) according to the manufacturer’s
instructions. The proteins were eluted in 25 mM
Tris-glycine, pH 8·0, with 0·3% SDS (w/v). The
protein was ﬁnally dialyzed against PBS, pH 7·4.
The rSjGST was puriﬁed by glutathione-Sepharose
aﬃnity chromatography using a 1 mL-GST-Trap
aﬃnity column setup in the Gradifrac system using
the method described by the manufacturer
(Amersham Biosciences).
Inbred male CBA/Ca mice (supplied by Charles
River, UK) were injected intraperitoneally, at
2-week intervals, with 0·1 mL of protein solution in
PBS (containing 10–50 µg of protein) adsorbed onto
an equal volume of aluminium hydroxide gel (alum)
as adjuvant. Protein concentrations were measured
using the Bradford Protein assay (Bio-Rad, UK).
Alum was prepared by mixing one volume of 10%
aluminium potassium sulphate with two volumes of
250 mM sodium hydroxide; the mixture was stirred
vigorously for 10 min and centrifuged at 1000 × g
for 10 min at RT. The pellet was then resuspended
in 150 mL sterile 0·9% sodium chloride solution,
and the suspension was stored at 4 °C until used.
Control mice received 0·2 mL alum suspension in
PBS. Blood samples were collected from a superﬁcial
vein 2 weeks after each injection. Sera were separated
by microcentrifugation at 13 000 × g for 5 min at RT
and stored separately for each animal at −20 °C until
analysis. The rabbit antiserum speciﬁc for SmCEwas
used as a positive control inWestern blots.Mice were
each challengedwith 200S.mansoni cercariae 2weeks
after receiving the last injection using previously
described methods (Smithers and Terry, 1965;
Doenhoﬀ et al. 1978a).
Assays
SDS–PAGE analysis and Western immunoblot-
ting. Protein samples were analysed on reducing
10 or 12% SDS–PAGE prepared as described else-
where (Laemmli, 1970). Protein Molecular Weight
Pre-Stained Standards (Amersham Pharmacia
Biotech, UK) were used to determine the molecular
weight of the proteins in the analysed samples.
SDS–PAGE gels were run using a Bio-Rad Mini
Protean II electrophoresis system and stained with
Coomassie Brilliant Blue R-250 (Bio-Rad) according
to the manufacturers’ instructions. Proteins sepa-
rated on SDS–PAGE gels were transferred electro-
phoretically to nitrocellulose membranes (NCP)
(Amersham Pharmacia Biotech, UK) as described
elsewhere (Towbin et al. 1979). Blots were cut into
strips; one of the strips was stained with
Protogold® colloidal gold solution (Agar Scientiﬁc,
UK) to visualize total proteins separated in the
loaded samples. The remaining strips were incu-
bated with the primary antibody solutions for 2 h
at RT, including rabbit antisera [all diluted 1/400
in PBS with Tween 20 (PBST)] or sera from immu- 
nized mice (diluted 1/200 in PBST). The NCP
strips were incubated with the appropriate second-
ary antibody (diluted 1/1000 in PBST): alkaline
phosphatase (AKP)-conjugated goat-anti-rabbit
immunoglobulin G (IgG) (Scottish Antibody
Production Unit) or AKP-conjugated-anti-mouse
IgG (Nordic Immunological Laboratories, The
Netherlands) for 2 h at RT. The membranes were
developed with 0·25 mg mL−1 5bromo-4chloro-
3indolyl-phosphate and 0·5 mg mL−1 nitroblue tet-
razoleum in 10 mL 0·1 M Tris–HCl, pH 9·0, 0·1 M
NaCl and 0·05 M MgCl2 (Sigma, UK) for 20 min
at RT.
Enzyme-linked immunosorbent assays (ELISA).
Indirect ELISA were performed to examine mouse
sera for presence of anti-elastase antibodies and
determine the endpoint titre (Voller et al. 1976).




























































ELISA plates (96-well ﬂat-bottomed, Thermo Life
Sciences, UK) were coated with 4 µg mL−1
SmCTF containing the native elastase in carbon-
ate/bicarbonate buﬀer, pH 9·0 (Sigma, UK)
(100 µL well−1 and overnight incubation at 4 °C).
After rinsing, the primary antibody-containing
mouse sera were added to the plates diluted 1/200
in PBST and the plates incubated for 2 h at RT.
Secondary antibodies [horseradish peroxidise
(HRP)-conjugated goat anti-mouse IgG, IgG1,
IgG2a or IgE (Nordic Immunological Laboratories,
The Netherlands)] were added (100 µL well−1) at
1/1000 dilution in PBST and incubated as above
with gentle agitation for 2 h at RT. Plates were
developed using 3, 3′, 5, 5′-tetramethyl benzidine
dihydrochloride (Sigma, UK) for 5–10 min, and
the reaction was stopped by addition of 50 µL of
2 M H2SO4. Absorbance at 450 nm was read using
an ELISA plate reader.
Assay for enzymatic activity of SmCE. Gelatinase
activity in samples containing ∼4 µg of protein was
tested on a pre-cast zymogram (gelatin) gel (10%
Tris-glycine gel with 0·1% gelatin as a substrate)
purchased from Invitrogen, UK. The procedure
was carried out as described in the manufacturer’s
manual. The gels were then stained with the
SimplyBlue Safe stain (Invitrogen, UK) according
to the manufacturer’s instructions.
Statistical procedures
All statistical calculations were performed using
GraphPad Prism software version 4.0 (San Diego,
California, USA). The signiﬁcance of the diﬀerence
between the immunized and the control groups
was determined by the Mann–Whitney U test.
Values of P< 0·05 were considered to be statistically
signiﬁcant.
RESULTS
Production and characterization of antigens used for
immunization
The native form of SmCE was puriﬁed from
SmCTF by continuous-elution gel electrophoresis.
Pooled fractions containing a doublet of ∼27–28 kDa
stained by Protogold after electrotransfer to NCPs
(Fig. 1A, lane 1) was shown to be reactive in immu-
noblots probed with an anti-27 kDa cercarial elastase
(SmCE) rabbit serum (Fig. 1A, lane 2). The plasmid
pGEXEL carrying the cDNA clone of the mature
SmCE-1a downstream of the SjGST was success-
fully constructed and transformed into E. coli cells
that were shown to express the transformed gene fol-
lowing induction by 0·5 mM isopropyl-β-D-thio-
galactoside at 30 °C for 60 min, the same for
SjGST. The puriﬁed rSmCE-SjGST that was
obtained in a soluble form in PBS (Fig. 1B, Lane
2) was antigenically reactive in Western blots
probed with a rabbit anti-SjGST serum (Fig. 1B,
lane 4) and an anti-SmCE serum prepared against
puriﬁed native 27 kDa SmCE (Fig. 1B, lane 6).
Puriﬁed SjGST (Fig. 1B, lane 1) was reactive in
Western blots with the rabbit anti-SjGST serum
(Fig. 1B, lane 3), but not with the rabbit anti-
SmCE serum (Fig. 1B, lane 5). The native SmCE
in SmCTF was enzymatically active in gelatin
zymogram gels, but neither the rSmCE-SjGST
nor the puriﬁed native SmCE was found to be pro-
teolytically active in the assay (data not shown).
Antibody responses to SmCTF, puriﬁed-native SmCE
and rSmCE-SjGST in mice
Four groups of six male CBA/Ca mice were immu-
nized intraperitoneally three times at 2-week
intervals. Group I (control) received only alum
on PBS. Groups II, III and IV received 10 µg elas-
tase protein per immunization in unfractionated
SmCTF (containing native/active SmCE), puriﬁed
native 27–28 kDa SmCE and puriﬁed rSmCE-
SjGST, respectively, all adsorbed onto alum. Sera
from groups III and IV immunized, respectively,
with puriﬁed, native, though enzymatically inactive,
SmCE and rSmCE-SjGST were shown to have
anti-elastase IgG antibodies starting from bleed 2
(Fig. 2A, III and IV). Sera from the control or
SmCTF-immunized mice – from all the bleeds –
did not show any reactivity to SmCE when exam-
ined 2 weeks after the second (Fig. 2A, I and II)
and the third immunizations (data not shown).
In a second experiment, three groups, each of 10
male CBA/Ca mice, were given four intraperitoneal
injections at 2-week intervals. Group I received only
alum in PBS, while groups II and III received 50 µg
mouse−1 of, respectively, rSjGST and rSmCE-
SjGST proteins on alum. In groups II and III, all
mice had IgG antibodies with speciﬁcity for rSjGST
(group II) or rSjGST and rSmCE (group III)
detected after just two injections, while no reactivity
against either rSjGST or rSmCE was detected in the
control group that received alum alone. The levels of
the anti-SmCE IgG produced after immunization
with rSmCE-SjGST were found to be statistically
signiﬁcantly higher (P< 0·05) when compared in
ELISA with groups I and II (Fig. 2B). Most of the
anti-SmCE IgG response was found to be IgG1
(P< 0·005 compared with control groups I and II)
(Fig. 2B) and no speciﬁc anti-SmCE IgEwas detected
(data not shown). Both immunized groups II and III
in this experiment were found to have lower mean
group worm burdens than the control group I with
the greater reduction seen in group III, which had
35·3% less worms. These mice (immunized with
rSmCE-SjGST) had, respectively, a mean of 42 and
45·8% fewer eggs than those received alum alone and




























































the rSjGST-immunizedmice in their livers (Table 1).
In another independent in vivo protection experiment
(eight mice per group), CBA/Ca mice that had
received three injections of 50 µg mL−1 rSjGST-
SmCE on alum had, respectively, a 25·1% reduction
in worm burden and a 40·6% reduction in liver eggs
count when compared with mice that received only
rSjGST. The protection data in both experiments
were, however, not statistically signiﬁcant due to a
large within-group variance (Table 1).
Immunological cross-reactivity of the cercarial
elastases of diﬀerent schistosome species
Western blots of SmCH, ShCH and SmrgCH
(150 µg lane−1) were probed with rabbit sera raised
against the native 27 kDa SmCE or ShCE. An anti-
genic doublet at 27–28 kDa in SmCH and one of
∼27 kDa in both ShCH and SmrgCH were found
to react in the blots probed with the rabbit anti-
SmCE- and anti-ShCE-speciﬁc sera (Fig. 3).
DISCUSSION
Vaccination may be the best way to obtain sustain-
able and long-term control of schistosomiasis
(Molehin et al. 2016). Our own studies have been
directed particularly at the SmCE. The enzymatic
activity of SmCE has been shown to be important
in penetration of deﬁnitive host skin (Cohen et al.
1991; Salter et al. 2002) and immune responsiveness
directed against this enzyme may therefore be host-
protective by directly preventing or delaying pene-
tration of cercariae. This antigen is of interest
because it seems not to be serologically recognized
in infected subjects (Bahgat et al. 2001) and which
(perhaps as a direct consequence of that property)
may play an important role in immune evasion
(Auriault et al. 1981; Marikovsky et al. 1988;
Darani et al. 1997; Pleass et al. 2000). The present
work is the ﬁrst, according to our knowledge, to
show that the inactive forms of the enzymes, includ-
ing a puriﬁed native SmCE and rSmCE-SjGST, are
more immunogenic in mice, compared with the
native, after just two injections. Our Western immu-
noblots showed that sera from mice immunized,
respectively, with enzymatically inactive, native
SmCE and rSmCE-SjGST proteins had anti-elas-
tase IgG antibody responses after two immuniza-
tions, while sera from mice immunized with the
native active enzyme did not show any reactivity to
SmCE till the end of the experiment at 2 weeks fol-
lowing the third immunization. Our ﬁnding is con-
sistent with a previous report by Darani et al.
(1997) who showed the native elastase to be poorly
immunogenic when injected into mice. Reasons for
the apparently poor immunogenicity of the native
enzyme may be a consequence of the enzyme’s
ability to degrade host immunoglobulins and com-



















Fig. 1. Western blot of native SmCE puriﬁed from SmCTF (A) and Coomassie Brilliant Blue-stained SDS–PAGE and
Western blot analysis of puriﬁed SmCE-SjGST and SjGST proteins (B). LaneM, protein molecular weight markers with
sizes as indicated; (A) lane 1, Protogold-stained blot showing puriﬁed SmCE present as a doublet of 27–28 kDa in the
sample; lane 2, Western blot of puriﬁed SmCE showing that the protein doublet of ∼27–28 kDa reacted with antibodies in
an anti-SmCE-speciﬁc rabbit antiserum. (B) Left-hand panel shows Coomassie Brilliant Blue-stained 10% SDS–PAGE
gel and central- and right-hand panels show Western blots probed with anti-rSjGST or anti-SmCE rabbit serum,
respectively; lanes 1, 3 and 5: puriﬁed rSjGST at ∼26 kDa (∼1 µg lane−1); lane 2, 4 and 6: puriﬁed rSmCE-SjGST at
∼53 kDa (∼1 µg lane−1).




























































1988; Darani et al. 1997; Pleass et al. 2000) or its
interaction with serine protease inhibitors in the
host (Mast et al. 1991; Modha and Doenhoﬀ,
1994a,b). TheQ5 latter was found to result in rapid
clearance of the enzyme from the circulation pre-
venting its normal processing by the antigen-pre-




















Fig. 2. Anti-SmCE antibodies in sera of mice immunized with SmCTF, puriﬁed SmCE or SmCE-SjGST after they had
received two immunizations (A) and levels of anti-elastase IgG, IgG1 and IgG2a in mice immunized with rSmCE-SjGST
by indirect ELISA 2weeks following the third immunization (B).M,molecular weight markers with sizes as indicated. (A)
Western blots of SmCTF (150 µg well−1) were probed with the following primary antibody: C, rabbit anti-SmCE serum;
I, lanes 1–6, mice sera from control mice received alum on PBS; II, lanes 7–12, sera from SmCTF-immunized mice; III,
lanes 13–17, sera from mice immunized with puriﬁed native SmCE; IV, lanes 18–23, sera from mice immunized with
puriﬁed recombinant SmCE-SjGST. Primary antibodies were detected with AKP-conjugated goat anti-rabbit or anti-
mouse IgG, both diluted 1/1000. The position of elastase doublet at 27/28 kDa is arrowed. (B) ELISA plates were coated
with SmCTF, probed with mouse sera and detected with HRP-conjugated goat anti-mouse IgG, IgG1 or IgG2a.
Columns represent mean absorbance readings for groups I (alum alone-injected mice), II (rSjGST-immunized mice) and
III (rSmCE-SjGST immunized mice). Error bars represent S.D. *P < 0·05, **P< 0·005.
Table 1. Eﬀect of rSmCE-SjGST immunization on S. mansoni worm and eggs burdens in mice
Groups








Control SjGST Control SjGST
Experiment-1 Control 74·60 ± 25·70 – – 33 998 ± 6513 – –
SjGST 55·60 ± 22·30 25·50 – 36 383 ± 11 318 −7·0 –
rSmCE-SjGST 48·30 ± 28·40 35·30 13·10 19714 ± 8096 42·0 45·8
Experiment-2 Control 55·30 ± 11·8 – – 24 643 ± 7707 – –
SjGST 59·40 ± 09·2 −7·4 – 31 400 ± 2251 −27·4 –
rSmCE-SjGST 44·50 ± 18·3 19·6 25·1 18 661 ± 7533 24·3 40·6




























































The SmCE-1a gene was used in the present study
to produce the rSmCE-SjGST. SmCE-1a is the
most highly expressed elastase isoform followed by
SmCE-1b: both are responsible for 90% of the
protein amount and activity (Salter et al. 2002;
Fitzpatrick et al. 2009). Alignment of the SmCE-
1a and SmCE-1b amino-acid sequences revealed
96·6% similarity, and the two isoforms were shown
to be functionally equivalent (Salter et al. 2002)
and immunologically cross-reactive (Darani, 1997).
In this work, our detection of the SmCE doublet
by a rabbit antiserum against the lower 27 kDa
SmCE in immunoblots indicates, in accordance,
that both isoforms may carry similar antigenic
epitopes. We have shown here that the rSmCE-
SjGST was antigenically reactive in Western
immunoblots probed by either an anti-SmCE
antiserum or anti-SjGST antibodies, indicating
fusion of SjGST to elastase did not abrogate
the antigenic properties of either of the fusion part-
ners. Immunization with rSmCE-SjGST induced
high levels of SmCE-speciﬁc total IgG and IgG1
in ELISA, the levels of both being statistically
signiﬁcantly higher when compared with alum
alone and SjGST controls. High levels of IgG1 and
low levels of IgG2a indicated a polarized Th2-
driven response (Mountford et al. 1994), though elas-
tase-speciﬁc IgE antibodies were absent in sera from
the rSmCE-SjGST-vaccinated mice. The latter
observation is an important consideration in vaccine
development, as speciﬁc IgE results in immediate-
type hypersensitivity reactions upon re-exposure to
an antigen rendering vaccines that induce IgE anti-
bodies potentially unsafe for use in humans. Such
an undesirable outcome was previously observed
with the hookworm Na-ASP-2 vaccine when it was
tested in humans (Bethony et al. 2008).
The 26 kDa GST (Sj26GST) used in immuniza-
tion in the present work is a fusion tag within the
backbone of pGEX-KG, a commercially available
bacterial expression plasmid (manufactured to
produce GST-fusion proteins). Although GSTs
were ﬁrst identiﬁed as vaccine candidates by Smith
et al. (1986), Sj26GST, unlike SmGST and
ShGST, was shown to have ‘unsatisfactory’ vaccin-
ating potential since it induced variable/inconsistent
protective immune responses to S. japonicum in
diﬀerent mouse strains (Davern et al. 1987; Scott
and McManus, 2000). In a previous research,
when used as a control for immunization with
another recombinant protein fused with SjGST,
GST derived from S. japonicum was ineﬀective in
reducing parasite burdens in a murine challenge
model of S. mansoni (Schechtman et al. 2001). The
latter results could possibly be a reﬂection of the
low level of antigenic cross-reactivity between
Sj26GST and the two GSTs (of, respectively, 26
and 28 kDa) of S. mansoni (Tiu et al. 1988; Henkle
et al. 1990). Our preliminary protective data
showed that mice that received rSjGST-SmCE on
alum had, respectively, 25 and 40·6% more reduc-
tions in worm and liver eggs counts than mice
receiving only rSjGST. In another independent
experiment in the present work, mice immunized
with rSmCE-SjGST had 45·8% reductions in liver
eggs counts than those immunized with rSjGST
alone. These mice had 35·3 and 42% fewer worms
and liver eggs than unimmunized controls. Similar
levels of protection (40%) with crude native SmCE
have been shown in the few mice that produced anti-
body against the enzyme (Darani et al. 1997).
However, the present preliminary results were not
statistically signiﬁcant due to large intra-group varia-



















Fig. 3. Western blots of cercarial homogenates from three diﬀerent schistosome species showing cross-reactivity of
∼27/28 kDa cercarial elastase molecules. Blots of cercarial homogenates of S. mansoni (left-hand panel), S. haematobium
(central hand panel) and S. margrebowiei (right-hand panel) were probed with rabbit sera raised against SmCE or ShCE.
Lane M, protein molecular weight markers with sizes as indicated; lane 1, blot probed with control sera from rabbits
immunized with Freund’s adjuvant alone; lane 2, blot probed with rabbit anti-SmCE sera; lane 3, blot probed with rabbit
anti-ShCE sera.




























































groups. Inappropriate re-folding of the recombinant
molecule may be the reason, even though some epi-
topes relevant to induction of protective immunity
in the latter were retained. We suggest that in order
to get consistent immunoprotective eﬀects in all
mice, it may be useful in future work to administer
an inactive elastase protein that is properly folded
with potentially immunoprotective B-cell epitopes
being thus retained. Fusion to other smaller,
relatively non-immunogenic tags may be helpful to
obtain a more properly folded protein and to
examine the immunoprotective capacity of the
recombinant elastase immunogen independent of
the SjGST.
Results of Western blots probed with 27 kDa
SmCE- and ShCE-speciﬁc antisera show that the
SmCE doublet is antigenically cross-reactive with a
similarly sized molecule in ShCH. A 27 kDa elastase
band in S. margrebowiei-cercarial extracts was also
reacted against by the anti-27 kDa SmCE and
ShCE rabbit antisera. The S. mansoni and S. haema-
tobium elastase major isoforms were shown by Salter
et al. (2002) to have similar protein sequences:
SmCE-1a and ShCE-1a were 93·9%, SmCE-1a and
ShCE-1b were 92·8%, SmCE-1b and ShCE-1a
were 93·9%, and SmCE-1b and ShCE-1b were
89·9 % similar. In addition, isoforms from the
same species, including SmCE-1a and SmCE-1b,
and ShCE-1a and ShCE-1b had, respectively, 96·6
and 98·6% sequence similarity. SmCE-1a and
SmCE-1b proteins were reported to have diﬀerent
molecular masses (Knudsen et al. 2005). In that
paper, a proteomic analysis of cercarial secretions
by Knudsen et al. (2005) revealed the presence of
SmCE-1a and SmCE-1b proteins with molecular
masses of 28·5 and 29·5 kDa, respectively, and align-
ment of the amino-acid sequences of the SmCE-1a
and SmCE-1b by BLAST revealed a diﬀerence in
length by an extra 10 amino acids in the latter,
perhaps indicating why in the present work the
SmCE protein appears as a doublet (the SmCE-1a
being most probably located in the lower ∼27 kDa
band). No data have been reported in the literature
for the relative sizes of respective elastase isoforms
from S. haematobium and S. margrebowiei to indicate
whether these enzymes would also appear as doub-
lets. The lack of complete amino-acid sequence
data for elastase isoforms of the latter species also
prevented comparative amino-acid alignment. The
present results may indicate that a vaccine based on
SmCE may also protect against S. haematobium as
well. The cross-reactivity shown here with a S. mar-
grebowiei, an important veterinary schistosome, may
allow the vaccine to be tested for eﬃcacy and safety
in animals before trials in humans, though the
reactivity of antibodies against the rSmCE protein
will need to be tested against native elastases from
the heterologous species.
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